183 related articles for article (PubMed ID: 21161315)
21. Xp11 translocation renal cell carcinoma with morphological features mimicking multilocular cystic renal neoplasm of low malignant potential: a series of six cases with molecular analysis.
Song Y; Yin X; Xia Q; Zheng L; Yao J; Zeng H; Nie L; Gong J; Zhou Q; Chen N
J Clin Pathol; 2021 Mar; 74(3):171-176. PubMed ID: 32699116
[TBL] [Abstract][Full Text] [Related]
22. Bilateral Xp11.2 translocation renal cell carcinoma: a case report.
Karashima T; Kuno T; Kuroda N; Satake H; Fukata S; Chikazawa M; Kawada C; Yamasaki I; Shuin T; Hiroi M; Inoue K
BMC Urol; 2018 Nov; 18(1):106. PubMed ID: 30458744
[TBL] [Abstract][Full Text] [Related]
23. RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.
Kato I; Furuya M; Baba M; Kameda Y; Yasuda M; Nishimoto K; Oyama M; Yamasaki T; Ogawa O; Niino H; Nakaigawa N; Yano Y; Sakamoto K; Urata Y; Mikami K; Yamasaki S; Tanaka R; Takagi T; Kondo T; Nagashima Y
Histopathology; 2019 Aug; 75(2):254-265. PubMed ID: 30908700
[TBL] [Abstract][Full Text] [Related]
24. The preliminary experiences of translocation renal cell carcinoma and literature review.
Su HH; Sung MT; Chiang PH; Cheng YT; Chen YT
Kaohsiung J Med Sci; 2014 Aug; 30(8):402-8. PubMed ID: 25002378
[TBL] [Abstract][Full Text] [Related]
25. Unravelling the mysteries of Xp11.2 translocation-associated renal cell carcinoma: A case report with a review of the literature.
Suneel R; Gupta P; Sekar A; Gupta N; Saxena A
Cytopathology; 2023 Jul; 34(4):367-376. PubMed ID: 37118914
[TBL] [Abstract][Full Text] [Related]
26. Renal cancer associated with Xp11.2 translocation/TFE3 gene fusion: Clinicopathological analysis of 13 cases.
Feng R; Tao Y; Chen Y; Xu W; Zhang G; Wang H
Ann Diagn Pathol; 2022 Jun; 58():151908. PubMed ID: 35149286
[TBL] [Abstract][Full Text] [Related]
27. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
[TBL] [Abstract][Full Text] [Related]
28. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.
Koie T; Yoneyama T; Hashimoto Y; Kamimura N; Kusumi T; Kijima H; Ohyama C
Int J Urol; 2009 Mar; 16(3):333-5. PubMed ID: 19298350
[TBL] [Abstract][Full Text] [Related]
29. XP11.2 translocation renal cell carcinoma: clinical experience of Taipei Veterans General Hospital.
Hung CC; Pan CC; Lin CC; Lin AT; Chen KK; Chang YH
J Chin Med Assoc; 2011 Nov; 74(11):500-4. PubMed ID: 22100019
[TBL] [Abstract][Full Text] [Related]
30. Combination of immunohistochemistry, FISH and RT-PCR shows high incidence of Xp11 translocation RCC: comparison of three different diagnostic methods.
Lee HJ; Shin DH; Noh GY; Kim YK; Kim A; Shin N; Lee JH; Choi KU; Kim JY; Lee CH; Sol MY; Rha SH; Park SW
Oncotarget; 2017 May; 8(19):30756-30765. PubMed ID: 28415646
[TBL] [Abstract][Full Text] [Related]
31. A rare case of TFE-related pigmented renal tumor with overlapping features between melanotic Xp11 translocation renal cancer and Xp11 renal cell carcinoma with melanotic features.
Cardili L; Wrublevsky Pereira G; Viana CR
Pathol Int; 2017 Apr; 67(4):208-213. PubMed ID: 28208226
[TBL] [Abstract][Full Text] [Related]
32. An adult Xp11.2 translocation renal carcinoma showing response to treatment with sunitinib.
Pwint TP; Macaulay V; Roberts IS; Sullivan M; Protheroe A
Urol Oncol; 2011; 29(6):821-4. PubMed ID: 19962921
[TBL] [Abstract][Full Text] [Related]
33. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions: clinical experience and literature review.
He J; Chen X; Gan W; Zhu B; Fan X; Guo H; Jia R
Future Oncol; 2015; 11(24):3243-52. PubMed ID: 26169997
[TBL] [Abstract][Full Text] [Related]
34. A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion.
Fukuda H; Kato I; Furuya M; Tanaka R; Takagi T; Kondo T; Nagashima Y
Virchows Arch; 2019 Mar; 474(3):389-393. PubMed ID: 30552521
[TBL] [Abstract][Full Text] [Related]
35. Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.
Hayes M; Peckova K; Martinek P; Hora M; Kalusova K; Straka L; Daum O; Kokoskova B; Rotterova P; PivovarĨikova K; Branzovsky J; Dubova M; Vesela P; Michal M; Hes O
Virchows Arch; 2015 Mar; 466(3):313-22. PubMed ID: 25544614
[TBL] [Abstract][Full Text] [Related]
36. [A case of xp11.2 translocation renal cell carcinoma].
Horie K; Kikuchi M; Miwa K; Minamidate Y; Yokoi S; Nakano M; Deguchi T; Ehara H; Asano N; Hirose Y
Hinyokika Kiyo; 2011 Mar; 57(3):129-33. PubMed ID: 21586884
[TBL] [Abstract][Full Text] [Related]
37. Cytopathology of Xp11 translocation renal cell carcinoma: a report of 5 cases.
Jin M; Parwani A; Li Z; Wakely PE
J Am Soc Cytopathol; 2020; 9(2):95-102. PubMed ID: 32029406
[TBL] [Abstract][Full Text] [Related]
38. Biological characteristics of pediatric renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.
Song HC; Sun N; Zhang WP; He L; Fu L; Huang C
J Pediatr Surg; 2014 Apr; 49(4):539-42. PubMed ID: 24726108
[TBL] [Abstract][Full Text] [Related]
39. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.
Komai Y; Fujiwara M; Fujii Y; Mukai H; Yonese J; Kawakami S; Yamamoto S; Migita T; Ishikawa Y; Kurata M; Nakamura T; Fukui I
Clin Cancer Res; 2009 Feb; 15(4):1170-6. PubMed ID: 19228722
[TBL] [Abstract][Full Text] [Related]
40. Kidney carcinoma associated with Xp11.2 translocation / TFE3 (ASPL-TFE3) gene fusion.
Salles PG; Soto M
Int Braz J Urol; 2005; 31(3):251-4. PubMed ID: 15992428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]